Financial statements Biotel
Balance sheet data of BIOTEL
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 8 124 405,74 | 7 969 521,25 | 6 793 886,51 | 5 984 238,13 | 5 855 635,10 | 5 624 094,92 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 8 124 405,74 | 7 969 521,25 | 6 793 886,51 | 5 984 238,13 | 5 855 635,10 | 5 624 094,92 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 8 124 405,74 | 7 969 521,25 | 6 793 886,51 | 5 984 238,13 | 5 855 635,10 | 5 624 094,92 |
| A. Equity | -107 697 187,81 | -10 736 966,76 | -13 765 589,41 | -14 093 305,69 | -14 276 801,69 | -14 273 892,74 |
| B. Liabilities and provisions for liabilities | 18 821 593,55 | 18 706 488,01 | 20 559 475,92 | 20 077 543,82 | 20 132 436,79 | 19 897 987,66 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.